| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 02/08/2006 | CN1240694C Process for preparation of tetrahydrofuran |
| 02/08/2006 | CN1240679C 2- and 2,5-substituted phenylketoenols |
| 02/08/2006 | CN1240660C Polyalkyl bicyclic derivative |
| 02/07/2006 | US6995269 Guanidinobenzamides |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/07/2006 | US6995156 Platelet adenosine diphosphate receptor antagonists |
| 02/07/2006 | US6994941 Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus |
| 02/07/2006 | US6994875 Process for obtaining a furan lipid-rich unsaponifiable material from avocado |
| 02/02/2006 | WO2006012385A2 Crystalline mycophenolate sodium |
| 02/02/2006 | WO2006012379A2 Processes for preparation of crystalline mycophenolate sodium |
| 02/02/2006 | WO2006012227A2 Amido compounds and their use as pharmaceuticals |
| 02/02/2006 | WO2006011469A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | WO2006011024A2 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/02/2006 | WO2006011000A1 Novel c6-substituted furanoid sugar amino acids and improved process for preparing the same |
| 02/02/2006 | WO2006010775A1 Tyrosine derivatives as ppar-gamma-modulators |
| 02/02/2006 | WO2006010287A1 Process for the preparation of optically-active compounds |
| 02/02/2006 | WO2005087692A3 Process for recovering organic compounds from aqueous streams containing same |
| 02/02/2006 | US20060025612 Gas phase synthesis of methylene lactones using novel catalyst |
| 02/02/2006 | US20060025611 Gas phase synthesis of methylene lactones using novel grafted catalyst |
| 02/02/2006 | US20060025610 Liquid phase synthesis of methylene lactones using novel catalyst |
| 02/02/2006 | US20060025609 Supercritical fluid phase synthesis of methylene lactones using oxynitride catlayst |
| 02/02/2006 | US20060025608 Reacting lactone with formaldehyde in solvent; high initial activity (conversion) and reactor productivity (mass of product per mass of catalyst per unit of time) |
| 02/02/2006 | US20060025607 Liquid phase synthesis of methylene lactones using novel grafted catalyst |
| 02/02/2006 | US20060025606 Gas phase synthesis of methylene lactones using oxinitride catalyst |
| 02/02/2006 | US20060025605 Supercritical fluid phase synthesis of methylene lactones using novel grafted catalyst |
| 02/02/2006 | US20060025604 Reacting lactone with formaldehyde; improved heat resistance |
| 02/02/2006 | US20060025594 Small molecule entry inhibitors |
| 02/02/2006 | US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists |
| 02/02/2006 | US20060025467 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
| 02/02/2006 | CA2574021A1 Tyrosine derivatives as ppar-gamma-modulators |
| 02/02/2006 | CA2573784A1 Crystalline mycophenolate sodium |
| 02/02/2006 | CA2573781A1 Processes for preparation of crystalline mycophenolate sodium |
| 02/02/2006 | CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | CA2571587A1 Quaternary salt ccr2 antagonists |
| 02/02/2006 | CA2570694A1 Amido compounds and their use as pharmaceuticals |
| 02/01/2006 | EP1621598A1 Divinylfluorenes. |
| 02/01/2006 | EP1620445A2 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/01/2006 | EP1620429A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/01/2006 | EP1620422A2 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 02/01/2006 | EP1620421A2 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
| 02/01/2006 | EP1620420A2 Substituted carboxylic acids |
| 02/01/2006 | EP1620419A2 Stabilized derivatives of ascorbic acid |
| 02/01/2006 | EP1620401A2 Phenyl substituted cyclic derivatives |
| 02/01/2006 | EP1620397A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders |
| 02/01/2006 | EP1620394A1 Method for crystallizing guanidinium salts |
| 02/01/2006 | EP1620093A2 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives |
| 02/01/2006 | EP1620086A1 Compounds that modulate ppar activity and methods of preparation |
| 02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 02/01/2006 | EP1390339B1 Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives |
| 02/01/2006 | CN1729199A Method for extracting 2-ketone-l-gulonic acid from a polar, preferably aqueous solvent |
| 02/01/2006 | CN1729181A Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/01/2006 | CN1729164A Process for the preparation of racemic citalopram diol and/or s- or r- citalopram diols and the use of such diols for the preparation of racemic citalopram, r-citalopram and/or s-citalopram |
| 02/01/2006 | CN1727348A Derivant of cephalosporin alkene, and preparation method |
| 02/01/2006 | CN1727339A Tricyclic compounds, their production and use |
| 02/01/2006 | CN1239495C Fungicides for control of take-all disease of plants |
| 02/01/2006 | CN1239492C Medication containing 1,6-methylene-[10]-annulene-furan and steroid |
| 02/01/2006 | CN1239491C Method for extracting total phenyl phthalein of ligusitcum wallichii |
| 02/01/2006 | CN1239490C Method for preparing sitaipulan |
| 02/01/2006 | CN1239489C Method for synthesizing conjugate vitaminc linoleate |
| 02/01/2006 | CN1239472C HIV integrase inhibitors |
| 02/01/2006 | CN1239467C Primary intermediates for oxidative coloration of hair |
| 01/31/2006 | US6992198 Method for the preparation of citalopram |
| 01/31/2006 | US6992197 Lactone compound |
| 01/31/2006 | US6992094 selenium nicotinic acid tetrahyronaphthaline compounds; treating skin disorders |
| 01/31/2006 | US6992081 Such as 4-((6-(3,5-difluoro-phenyl)-5-(S)-(3-dipropylcarb-amoyl-benzoyl-amino)-2-(R)-ethyl-4-(S)-hydroxy-hexanoylamino)-methyl)-cyclohexanecarboxylic acid for inhibiting secretase activity and cleavage of amyloid precursor protein |
| 01/31/2006 | CA2347599C Process for the preparation of pyrimidine compounds |
| 01/31/2006 | CA2186991C Process for the preparation of acyl isocyanates |
| 01/31/2006 | CA2119261C Novel sidechain-bearing taxanes and intermediates thereof |
| 01/26/2006 | WO2006010082A1 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase |
| 01/26/2006 | WO2006007896A1 Novel o-aminophenol derivatives and colorants containing said compounds |
| 01/26/2006 | WO2005105766A3 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them |
| 01/26/2006 | WO2005069981A3 Method of preparation of benzofuran-2-carboxylic acid {(s)-3-methyl-1-[(4s, 7r)-7methyl-3-oxo-1-(pyridine-2-sulfonyl)-azepan-4-ylcarbamoyl]-butyl}-amide |
| 01/26/2006 | WO2005061476A3 Aroylfuranes and aroylthiophenes |
| 01/26/2006 | WO2005055959A3 Bulky monomers leading to resins exhibiting low polymerization shrinkage |
| 01/26/2006 | US20060020140 RS-citalopram diol is precipitated from a solution of the initial non-racemic mixture, or R- or S-citalopram diol is dissolved into a solvent from the initial non-racemic mixture, leaving a residue of RS-citalopram diol; and the precipitate formed is is separated from the final solution phase; simplified |
| 01/26/2006 | US20060020135 Long chain aliphatic alcohol derivatives and methods of making and using same |
| 01/26/2006 | US20060020003 Biphenyloxy-acids |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/26/2006 | CA2574180A1 Substituted benzothiazoles |
| 01/26/2006 | CA2572753A1 Novel o-aminophenol derivatives and colorants containing said compounds |
| 01/25/2006 | EP1619189A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives |
| 01/25/2006 | EP1619180A1 CaSR ANTAGONIST |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | EP1255746B1 Oxy- and amino-substituted tetrahydrofuryl derivatives with antimour activity |
| 01/25/2006 | EP1097158B1 Ligands for metals and metal-catalyzed processes |
| 01/25/2006 | CN1726202A Crystalline escitalopram hydrobromide and methods for preparing the same |
| 01/25/2006 | CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 01/25/2006 | CN1726026A Antioxidant for fats, oils and food |
| 01/25/2006 | CN1726025A Triptolide derivatives as immunomodulator and anticancer agents |
| 01/25/2006 | CN1724528A Preparation methd of 2,2',3,4'-diphenyl thioether tetra acid dianhydride |
| 01/25/2006 | CN1724527A Application of fraxiketone as medicine for treating liver disease |
| 01/25/2006 | CN1724526A Synthesis method of ranitidine alkali and its hydrochloride |
| 01/25/2006 | CN1724525A Gamma-butyrolactone derivative and its preparation method |
| 01/25/2006 | CN1238357C Hypoxylonin and its preparation method and application |
| 01/25/2006 | CN1238349C Synthesis method of L-ascorbic acid multiester compound |
| 01/25/2006 | CN1238323C Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds |
| 01/24/2006 | USRE38947 Method of enantioselectively catalyzing a reaction |
| 01/24/2006 | US6989455 Supplying to the first hydrogenation zone a maleic acid feedstock, reacting feedstock with hydrogen in presence of hydrogenation catalyst to produce succininc acid, reacting in second zone the product with hydrogen and IInd catalyst |